|
|
||||||||
1 Departments of Pharmacology and Toxicology and Physiology, Medical College of Wisconsin, Milwaukee 53226; and 2 Department of Physiology, University of Wisconsin Medical School, Madison, Wisconsin 53706
| |
ABSTRACT |
|---|
|
|
|---|
The present study was designed to test the hypothesis that cADP-ribose (cADPR) increases Ca2+ release through activation of ryanodine receptors (RYR) on the sarcoplasmic reticulum (SR) in coronary arterial smooth muscle cells (CASMCs). We reconstituted RYR from the SR of CASMCs into planar lipid bilayers and examined the effect of cADPR on the activity of these Ca2+ release channels. In a symmetrical cesium methanesulfonate configuration, a 245 pS Cs+ current was recorded. This current was characterized by the formation of a subconductance and increase in the open probability (NPo) of the channels in the presence of ryanodine (0.01-1 µM) and imperatoxin A (100 nM). A high concentration of ryanodine (50 µM) and ruthenium red (40-80 µM) substantially inhibited the activity of RYR/Ca2+ release channels. Caffeine (0.5-5 mM) markedly increased the NPo of these Ca2+ release channels of the SR, but D-myo-inositol 1,4,5-trisphospate and heparin were without effect. Cyclic ADPR significantly increased the NPo of these Ca2+ release channels of SR in a concentration-dependent manner. Addition of cADPR (0.01 µM) into the cis bath solution produced a 2.9-fold increase in the NPo of these RYR/Ca2+ release channels. An eightfold increase in the NPo of the RYR/Ca2+ release channels (0.0056 ± 0.001 vs. 0.048 ± 0.017) was observed at a concentration of cADPR of 1 µM. The effect of cADPR was completely abolished by ryanodine (50 µM). In the presence of cADPR, Ca2+-induced activation of these channels was markedly enhanced. These results provide evidence that cADPR activates RYR/Ca2+ release channels on the SR of CASMCs. It is concluded that cADPR stimulates Ca2+ release through the activation of RYRs on the SR of these smooth mucle cells.
adenosine 3',5'-cyclic diphosphate-ribose; calcium mobilization; vascular smooth muscle; coronary artery
| |
INTRODUCTION |
|---|
|
|
|---|
CYCLIC ADP-RIBOSE
(cADPR) serves as a second messenger to mediate intracellular
Ca2+ mobilization independently of the
D-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] signaling pathway in different tissues or
cells (8-11, 22-26). This cADPR-mediated
Ca2+ signaling participates in the regulation of a variety
of cell functions or cellular activities such as the secretion of
insulin from pancreatic
-cells, the fertilization of eggs, cell
growth, neuronal activity, and the effects of nitric oxide in nonmuscle tissues (1, 11, 23, 40, 46). Recent studies in our laboratory and by others (12, 19, 30, 31, 47) demonstrate that cADPR induced Ca2+ release from intracellular stores
of coronary arterial smooth muscle cells and that the inhibition of the
production of cADPR results in the relaxation of coronary arteries.
However, the mechanism by which cADPR activates Ca2+
mobilization is poorly understood. With the use of pharmacological approaches, cADPR has been found to activate or modulate ryanodine receptors (RYR) on the sarcoplasmic reticulum (SR) of nonvascular tissues (9, 10, 15, 22, 23, 28).
[3H]Ryanodine binding assays have indicated that cADPR
may increase or decrease ryanodine binding on the SR depending on
different tissues (7, 35). These results suggest that
cADPR may be an endogenous regulator or modulator of the RYR. A recent
study (37) has reported that cADPR may bind to an
accessary protein of RYR, FK506 binding proteins, and thereby activate
these receptors of the SR.
It is not known how cADPR produces Ca2+ mobilization in vascular smooth muscle cells. However, RYRs are found in arterial smooth muscle cells, and they can mediate Ca2+ release from these cells and participate in the control of vascular tone and vasomotor response (2, 15, 18, 34). The RYR is a homotetramer with molecular weight of ~550 kDa for each monomer. Four monomers comprise a high-conductance Ca2+ channel pore on the membrane of the SR, which is responsible for Ca2+ release. Three subtypes of the RYR with specific tissue distributions are now recognized and named as RYR1, RYR2, and RYR3. Cytosolic Ca2+ is a primary activating ligand of these RYR, and the binding of Ca2+ to the RYR activates Ca2+ release. Therefore, RYR has been proposed to mediate Ca2+-induced Ca2+ release (CICR) (6, 15, 20, 21, 32, 44). Studies using ligand binding and molecular approaches demonstrate that RYR3 is a predominant form on the SR of vascular smooth muscle cells (6). It has yet to be determined whether cADPR directly activates these RYR/Ca2+ release channels.
The present study was designed to test the hypothesis that cADPR produces Ca2+ release through activation of RYR/Ca2+ release channels on the SR of coronary arterial smooth muscle cells (CASMCs). We reconstituted the RYR/Ca2+ release channels from the SR of CASMCs into a planar lipid bilayer and determined the biophysical and pharmacological characteristics of these channels. We then examined the effect of cADPR on the activity of these RYR/Ca2+ release channels. Because caffeine is a well-known activator of the RYR (21, 22), we also determined the effect of caffeine on the activity of these reconstituted RYR/Ca2+ release channels.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Preparation of SR membrane from bovine coronary arteries.
Coronary arteries were dissected from the bovine heart, and SR-enriched
microsomes (SR membrane) of these arteries were prepared as described
previously (14, 29, 31, 32). Briefly, the dissected
coronary arteries (outer diameter 500-1,500 µm) were cut
into small pieces and homogenized with a Tenbroeck glass tissue grinder
in ice-cold MOPS buffer containing 0.9% NaCl, 10 mM MOPS (pH 7.0), 2 µM leupeptin, and 0.8 µM benzamidine. The homogenate was
centrifuged at 4,000 g for 20 min at 4°C, and the
supernatant was further centrifuged at another 8,000 g for
20 min at 4°C and then at 40,000 g for 30 min. The pellet,
termed the SR membrane, was resuspended in a solution containing 0.9%
NaCl, 0.3 M sucrose, and 0.1 µM phenylmethylsulfonyl fluoride,
aliquoted, frozen in liquid N2, and stored at
80°C
until use (32).
Reconstitution of RYR into planar lipid bilayer.
The SR membranes from CASMCs were reconstituted into planar lipid
bilayers as described by Lokuta et al. (32, 33). Briefly, phosphatidylethanolamine and phosphatidyl-serine (1:1) were dissolved in decane (25 mg/ml) and used to form a planar lipid bilayer in a
250-µm aperture between two chambers filled with cis and
trans solutions, respectively. The SR membranes (50-100
µg) were added into the cis solution, which corresponded
to the cytosolic side of the SR channels. The trans solution
represented the lumenal side of these SR channels. The recording
solution in the cis chamber was 300 mM cesium
(Cs+) mechanesulfonate and 10 mM MOPS (pH 7.2). The
trans solution was the same as the cis solution
except that cesium methanesulfonate was 50 mM before fusion and 300 mM
after fusion. In this configuration, Cs+ flows from the
lumenal (trans) to the cytosolic (cis) side at negative holding potentials. Cs+, instead of
Ca2+, was chosen as the charge carrier to precisely control
[Ca2+] around the channel, to increase the channel
conductance
(GCs+/GCa2+ = ~2), and to avoid interference from K+ channels present
in the SR membrane. Cl
channels were blocked by replacing
chloride with the impermeant anion methanesulfonate. The
Ca2+ release channel activity was detected in a symmetrical
cesium methanesulfonate solution (300 mM) in all experiments. To
increase the channel activity, 1 µM free Ca2+ in the
cis solution was adjusted by adding Ca2+
standard solution containing CaCl2 and EGTA as described
previously (32, 33).
Recordings of RYR/Ca2+ release
channel currents.
An integrating bilayer clamp amplifier (model BC-525C, Warner
Instrument) was used to record single-channel currents. The amplifier output signals were filtered at 1 kHz with an eight-pole Bessel filter (Frequency Devices). Currents were digitized at a
sampling rate of 10 kHz and stored on the hard disk of a Micron Pentium
III computer for off-line analysis. Data acquisition and analysis were
performed with pCLAMP software (version 7.01, Axon Instruments).
Channel open probability (NPo) in the lipid bilayer was
determined from recordings of 3-5 min as described previously in
our patch-clamp studies (30, 31). All lipid bilayer
experiments were performed at room temperature (
20°C).
40 to +40 mV in steps of 10 mV. Ryanodine (0.1-50 µM), caffeine (0.5-5 mM), imperatoxin
A (0.01 µM), and ruthenium red (40-80 µM) were used as
blockers or activators to characterize RYR/Ca2+ release
channels in the lipid bilayer. Ins(1,4,5)P3 (10 µM) and heparin (25 mg/ml), an Ins(1,4,5)P3 receptor
[Ins(1,4,5)P3R] antagonist, were used to distinguish
RYR/Ca2+ release channels from
Ins(1,4,5)P3-sensitive Ca2+channels on the SR
membrane. The effect of cADPR (0.01-1 µM) on Ca2+
release channels of the SR was defined in the absence or presence of
ryanodine. To determine the effect of cADPR on the Ca2+
sensitivity of the channels, the concentration of ionized
Ca2+ in the cis solution was varied from
10
7 to 10
5 mol/l in the absence or presence
of cADPR. All of the compounds used in these experiments were added
into the cis solution, and currents were recorded at holding
potentials at
40 mV.
Statistics. Data are presented as means ± SE; the significance of the differences in mean values between and within multiple groups was examined using an analysis of variance for repeated measures followed by a Duncan's multiple range test. A Student's t-test was used to evaluate statistical significance of differences between two paired observations. P < 0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Recordings of reconstituted Ca2+
release channel currents of SR membranes from CASMCs.
With symmetrical cesium in cis and trans
solutions, a unitary Cs+ current through the reconstituted
receptor/channel complex in the lipid bilayer was detected at holding
potentials from
40 to +40 mV (Fig.
1A). Mean slope conductance
for these SR Cs+ currents was 245 ± 4.5 pS with a
reversal potential of ~0 mV (Fig. 1B). The NPo
of these Cs+ currents increased when the bilayer holding
potential increased from 0 to +40 mV or decreased from 0 to
40 mV,
suggesting that the channel activity is dependent on the magnitude of
holding potentials rather than the polarity of clamp voltage. The
NPo of these Cs+ currents was 0.0056 ± 0.001 at a bilayer holding potential of +40 mV.
|
Pharmacological characteristics of reconstituted
RYR/Ca2+ release channels.
Several pharmacological approaches were used to further characterize
and identify the Cs+ currents in the lipid bilayer as
ryanodine-sensitive Ca2+ release channels. First, the
effects of ryanodine on the Cs+ currents were examined.
Figure 2A depicts the
representative recordings of single-channel Cs+ currents
before and after the addition of ryanodine into the cis
solution. Ryanodine increased channel activity and induced a
subconductance state of Cs+ currents, as showed by a 50 or
75% decrease in the amplitude of these Cs+ currents.
Ryanodine increased the NPo of these currents at
concentrations <20 µM. However, when a high concentration of
ryanodine (50 µM) was administered into the cis solution,
the channel openings were blocked. Figure 2B summarizes the
results of these experiments. Ryanodine at concentrations of
0.1-10 µM increased the NPo of these channels in a
concentration-dependent manner. The NPo was increased from
0.0042 ± 0.001 of control to 0.025 ± 0.001 in the presence
of 10 µM ryanodine. However, ryanodine at concentrations >20 µM
significantly inhibited the channel activity in this
preparation.
|
|
Effect of CICR inhibitor ruthenium red and activator caffeine on
activity of reconstituted RYR/Ca2+
release channels.
The effects of ruthenium red on the NPo of reconstituted
Cs+ currents are also presented in Table 1. Addition of
ruthenium red at concentrations of 40-80 µM markedly reduced the
NPo of these channels. A 68% inhibition was observed with
80 µM ruthenium red. The CICR activator caffeine significantly
increased the activity of the reconstituted Ca2+ channels
(Fig. 3). Figure 3A shows the
representative recordings of Cs+ currents under control
condition and after addition of caffeine in the cis
solution. Caffeine at a concentration of 1 mM markedly increased the
activity of these reconstituted channels. Figure 3B
summarizes the effects of caffeine on the NPo of the
reconstituted Ca2+ release channels. Caffeine at
concentrations of 0.5-5 mM produced a concentration-dependent
increase in the NPo of these channels. Maximal increase was
observed at 1 mM caffeine added into the cis solution.
|
Effect of cADPR on activity of reconstituted
RYR/Ca2+ release channels.
The representative recordings depicting the effect of cADPR on the
activity of reconstituted RYR/Ca2+ release channels of
CASMCs are presented in Fig.
4A. These Cs+
currents markedly increased when cADPR (1 µM) was added into the
cis solution. In the presence of 50 µM ryanodine in the
cis solution, cADPR-induced activation of the channels was
blocked. Figure 4B summarizes the concentration-dependent
effect of cADPR on the NPo of the reconstituted
RYR/Ca2+ release channels. cADPR at concentrations of 0.01 µM produced a 2.9-fold increase in the NPo of these
channels (0.006 ± 0.001 vs. 0.018 ± 0.002). An eightfold
increase in the NPo of the channels (0.006 ± 0.001 vs. 0.048 ± 0.01) was observed with 1 µM cADPR. This
cADPR-induced increase in the channel NPo was completely abolished by pretreatment of the bilayer membrane with 50 µM
ryanodine (in the cis solution). ADP-ribose, a structural
analog of cADPR, even at 10 µM had no effect on the activity of these
channels.
|
Effect of cADPR on Ca2+ sensitivity
of reconstituted RYR/Ca2+ release
channels.
Because RYR mediate CICR, cytosolic Ca2+ should activate
RYR/Ca2+ release channels. To test this hypothesis, the
effect of Ca2+ on the activity of reconstituted
RYR/Ca2+ release channels was examined. As shown in Fig.
5A, a CaCl2 and EGTA mixture was added into the cis solution to adjust
[Ca2+] to 10
7-10
5 M. CaCl2 (10
5 M) significantly increased the
activity of these RYR/Ca2+ release channels. In the
presence of cADPR, Ca2+-induced activation of these
channels was markedly enhanced. As summarized in Fig. 5B,
CaCl2 (10
5 M) increased the NPo
of these RYR/Ca2+ release channels. Addition of cADPR into
the cis solution significantly potentiated Ca2+
activation of these channels. At 10 µM, CaCl2 produced a
2.5-fold increase in the NPo of these channels and a 5-fold
increase in the NPo of these channels in the presence of
cADPR in the cis solution.
|
| |
DISCUSSION |
|---|
|
|
|---|
The presence of the RYR has been documented in the vascular smooth
muscle cells, and CICR, associated with activation of these SR
receptors, participates in the control of vascular tone (6, 15,
20, 21, 32, 44). Numerous studies using pharmacological approaches have shown that the RYR mediates Ca2+ release
independently of the Ins(1,4,5)P3 pathway in vascular smooth muscle cells and thereby plays an important role in the regulation of vascular tone (6, 15, 20, 21, 32, 44). RYR-mediated CICR may contribute to the vasoconstrictor response to
membrane depolarization, Ca2+ influx, caffeine, or some
agonists such as endothelin, PG F2
and histamine
(16, 17, 19, 31, 34, 43, 45). Recent studies using
molecular and electron microscopic approaches have demonstrated the
localization of RYR in the SR of vascular smooth muscle cells
(27). With the use of electrophysiological methods, the
RYR/Ca2+ release channels currents were recorded across
planar lipid bilayers reconstituted with aortic SR (14).
These studies suggest that the RYR is the Ca2+-gated
Ca2+ channel on the SR (14). In the present
study, we reconstituted RYRs from the SR of bovine coronary arterial
smooth muscle into a planar lipid bilayer and examined their
biophysical and pharmacological features and the regulatory effect of
cADPR on the activity of these channels. With the use of cesium as the
charge carrier, which is widely used to study the RYR in skeletal and
cardiac muscles (32, 33, 44), a calcium channel with a
conductance of 245 pS was detected in the SR of bovine CASMCs. In a
recording configuration with symmetrical cesium, this Cs+
current exhibited a reversal potential at ~0 mV, and its
NPo was dependent on the magnitude of the holding potential
across the lipid bilayer. Compared with the RYR/Ca2+
release channels in skeletal and cardiac muscle, the conductance of
RYR/Ca2+ release channels in coronary arterial smooth
muscle was relatively small. It has been reported that the conductance
of RYR/Ca2+ release channels was ~500-1,000 pS in
either skeletal muscle or cardiac muscle (6, 33, 44). In
addition, a higher concentration of the coronary arterial SR (100 µg)
was needed for reconstitution and recording of these channels in the
lipid bilayer compared with skeletal and cardiac muscle (~10-20
µg SR). This suggests that RYR may be less enriched in the SR of
vascular smooth muscle than skeletal or cardiac muscle.
To further characterize RYR/Ca2+ release channels, we tested the effects of several specific RYR blockers or activators on the activity and conducting properties of these channels. Addition of the RYR ligand ryanodine at low concentrations into the cis solution significantly reduced the amplitude of Cs+ currents and increased the NPo, but a high concentration of ryanodine (50 µM) inactivated these channels. These results are consistent with previous studies indicating that ryanodine activates RYR/Ca2+ release channels and results in a subconductance state of these channels (6). Imperatoxin A has a similar action pattern to ryanodine and is widely used for characterization of RYR/Ca2+ release channels (13, 42, 48). It also resulted in a subconductance state of the Cs+ currents and increased the NPo of these currents. These results suggest that the Cs+ currents recorded in our preparation are ryanodine sensitive and represent RYR/Ca2+ release channels from CASMCs. Because RYRs have been reported to mediate CICR, we examined the effects of the CICR inhibitor ruthenium red and CICR activator caffeine on the activity of these RYR channels. The NPo of these channels was significantly decreased by ruthenium red and increased by caffeine. The amplitude of the currents was not altered by these drugs. These effects of ruthenium red and caffeine are similar to those described for the RYR/Ca2+ release channels of skeletal and cardiac muscles (6, 33) and aortic SR (14). These findings indicated that this reconstituted channel from CASMCs exhibits the major pharmacological property of the RYR/Ca2+ release channel of striated muscle.
The present study demonstrated that the Cs+ currents recorded in the lipid bilayer were not altered by either Ins(1,4,5)P3 or the Ins(1,4,5)P3R antagonist heparin, suggesting that these channels are not Ins(1,4,5)P3R-associated Ca2+ release channels. Previous studies reported that Ins(1,4,5)P3R were abundantly expressed in the SR of CASMCs and also possessed the properties of receptor-operated ion channels. Like RYR, these Ins(1,4,5)P3R allow the flow of Ca2+ from intracellular stores to the cytoplasm in response to Ins(1,4,5)P3 binding (3, 5). However, the present study did not detect these Ins(1,4,5)P3R-associated Ca2+ release channels. The reason for the lack of Ins(1,4,5)P3 channels in our reconstitution remains unknown. It may be due to the biophysical properties of the Ins(1,4,5)P3R or our recording configuration. In general, the conductance of Ins(1,4,5)P3R/Ca2+ release currents is fourfold less than that of the RYR (3), and, therefore, a high gradient of the charge carrier or a high level of holding potential between the cis and trans solutions is needed for the recording of Ins(1,4,5)P3R activity in the lipid bilayer. In our experiments with a symmetrical Cs+ solution, if we increased the holding potential to more than 60 mV, we could record a small current (~1 pA, data not shown). However, under this condition, the large currents and active opening of the RYR/Ca2+ release channels often broke the lipid bilayer across the aperture. Considering that the present study mainly focused on the effect of cADPR on the activity of RYR/Ca2+ release channels, we did not characterize these small currents, which may represent Ins(1,4,5)P3R-mediated Ca2+ channels. In addition, to activate and stabilize the channels in our bilayer, we routinely included 1 µM Ca2+ in the cis solution. This concentration of Ca2+ could completely block the Ins(1,4,5)P3R activity. These receptors exhibited a bell-shaped Ca2+ dependence: the activity of the Ins(1,4,5)P3R/Ca2+ release channels increased as the free Ca2+ concentration was elevated from 10 to 250 nM and decreased at Ca2+ concentrations above 250 nM (3). Thus the presence of 1 µM free Ca2+ in the cis solution may be another important reason for the lack of Ins(1,4,5)P3R channel activity in our preparation.
An important finding in the present study is that cADPR increased the NPo of the reconstituted RYR/Ca2+ release channels from CASMCs. Addition of cADPR to the cis solution markedly increased the NPo of these Ca2+ channels of the SR at concentrations as low as 10 nM. In the presence of ryanodine (50 µM), the cADPR-mediated increase in the RYR/Ca2+ release channels was completely abolished. These results provide direct evidence that cADPR activates the RYR and may thereby produce Ca2+ release. This cADPR-mediated activation seems to be associated with increased Ca2+ sensitivity of RYR/Ca2+ channels, because the Ca2+ concentration-response curve of the channel activity was significantly shifted to the left in the presence of cADPR. Previous studies demonstrated that cADPR-mediated Ca2+ mobolization was blocked by pretreatment of the cells or the SR with ryanodine or RYR antagonists in a variety of vertebrate cells, including those from the brain and myocardium and sympathetic neurons, pancreatic acinar cells, and pituitary cells (35; see Ref. 39 for review), suggesting that RYRs mediate the effect of cADPR. The present study further supports this view. However, there is evidence indicating that cADPR releases Ca2+ independently of the RYR in some cells such as neurons and those from the myocardium and smooth muscle (19, 21). With the use of channel reconstitution techniques, Sitsapesan et al. (38) demonstrated that cADPR did not directly activate RYR in the SR from cardiac muscle. The reason for these discrepancies remains unknown. It is possible that there is a tissue-specific effect of cADPR on the RYR. This tissue-specific effect may be associated with the intermediate proteins or accessary proteins that regulate RYR activity. It has been reported that calmodulin is essential for the activation of cADPR-induced Ca2+ release in sea urchin eggs (23, 26, 41). A recent study (37) has demonstrated that a RYR accessary protein, FK506 binding protein, may have a binding site of cADPR and that cADPR activates RYRs through binding to this accessary protein. Further studies are needed to elucidate the role of these regulatory proteins in mediating the action of cADPR.
The present study did not attempt to address the physiological
relevance of cADPR-mediated activation of RYR. It is possible that this
RYR activation by cADPR plays a role in the control of basal vascular
tone and vasomotor response to agonists. Under the resting condition,
the intracellular [Ca2+] in vascular smooth muscle is
dependent on the Ca2+ influx, spontaneous brief bursts of
calcium released from the SR into the cytoplasm, and CICR
(2). cADPR may participate in the control of the resting
Ca2+ levels in these smooth muscle cells through RYR or
CICR (2, 23, 25). In regard to the agonist response, there
is increasing evidence suggesting that cADPR may serve as a second
messenger to mediate the Ca2+-mobilizing effects of a
number of agonists. Studies using pancreatic
-cells strongly
suggested that cADPR mediates glucose-induced insulin secretion
(40). It has been reported that cADPR may mediate the
effects of acetylcholine receptors in adrenal chromaffin cells, 5-HT 2B
receptors in arterial endothelial cells, and retinoic acid receptors in
renal tubular cells and aortic smooth muscle (1, 4, 36,
43). Cholecystokinin and 5-HT may act through the cADPR
pathway in longitudinal intestinal smooth muscle and tracheal smooth
muscle (see Ref. 11 for review). It remains unknown which
type of agonist acts through the cADPR signaling pathway in coronary
arterial smooth muscle. However, to answer this question, considerable
investment and effort will first be required to advance the technology
for quantitation of basal level of intracellular cADPR and to develop
more specific and potent cADPR antagonists.
In summary, the present study detected a RYR/Ca2+ release channel current of 254 pS in the planar lipid bilayer incorporated with the SR of coronary arterial smooth muscle. cADPR activated these reconstituted RYR/Ca2+ release channels and produced Cs+ flow across the bilayer. It is concluded that activation of the RYR/Ca2+ release channels is an important mechanism mediating cADPR-induced intracellular Ca2+ mobilization in CASMCs.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported National Heart, Lung, and Blood Institute Grants HL-57244 and HL-51055 and American Heart Association Established Investigator Grant 9940167N.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: P.-L. Li, Dept. of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226 (E-mail: pli{at}post.its.mcw.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 7 July 2000; accepted in final form 28 August 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Beers, KW,
Chini EN,
and
Dousa TP.
All-trans-retinoic acid stimulates synthesis of cyclic ADP-ribose in renal LLC-PK1 cells.
J Clin Invest
95:
2395-2390,
1995.
2.
Berridge, MJ.
Elementary and global aspects of calcium signalling.
J Physiol (Lond)
499:
291-306,
1997[ISI][Medline].
3.
Bezprozvanny, I,
and
Ehrlich BE.
The inositol 1,4,5-triphosphate (InsP3) receptor.
J Membr Biol
145:
205-216,
1995[ISI][Medline].
4.
De Toledo, FG,
Cheng J,
and
Dousa TP.
Retinoic acid and triiodothyronine stimulate ADP-ribosyl cyclase activity in rat vascular smooth muscle cells.
Biochem Biophys Res Commun
238:
847-850,
1997[ISI][Medline].
5.
Ehrlich, BE,
and
Watras J.
Inositol 1,4,5-triphosphate activates a channel from smooth muscle sarcoplasmic reticulum.
Nature
336:
583-586,
1988[Medline].
6.
Franzini-Armstrong, C,
and
Protasi F.
Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions.
Pharmacol Rev
77:
699-729,
1997.
7.
Fruen, BR,
Mickelson JR,
Shomer NH,
Velez P,
and
Louis CF.
Cyclic ADP-ribose does not affect cardiac or skeletal muscle ryanodine receptors.
FEBS Lett
352:
123-126,
1994[ISI][Medline].
8.
Galione, A.
Cyclic ADP-ribose: a new way to control calcium.
Science
259:
325-326,
1993
9.
Galione, A.
Cyclic ADP-ribose, the ADP-ribosyl cyclase pathway and calcium signalling.
Mol Cell Endocrinol
98:
125-131,
1994[ISI][Medline].
10.
Galione, A,
Lee HC,
and
Busa WB.
Ca2+-induced Ca2+ release in sea urchin egg homogenates and its modulation by cyclic ADP-ribose.
Science
253:
1143-1146,
1991
11.
Galione, A,
and
Sethi J.
Cyclic ADP-ribose and calcium signaling.
In: Biochemistry of Smooth Muscle Contraction, edited by Barany M.. New York: Academic, 1996, p. 295-305.
12.
Geiger, J,
Zou A-P,
Campbell WB,
and
Li PL.
Inhibition of cyclic ADP-ribose formation produces vasodilation in bovine coronary arteries.
Hypertension
35:
397-402,
2000
13.
Gurrola, GB,
Arevalo C,
Sreekumar R,
Lokuta AJ,
Walker JW,
and
Valdivia HH.
Activation of ryanodine receptors by imperatoxin A and a peptide segment of the II-III loop of the dihydropyridine receptor.
J Biol Chem
274:
7879-7886,
1999
14.
Herrmann-Frank, A,
Darling E,
and
Meissner G.
Functional characterization of the Ca2+-gated Ca2+ release channel of vascular smooth muscle sarcoplasmic reticulum.
Pflügers Arch
418:
353-359,
1991[ISI][Medline].
15.
Ito, K,
Ikemoto T,
and
Takakura S.
Involvement of Ca2+ influx-induced Ca2+ release in contractions of intact vascular smooth muscles.
Am J Physiol Heart Circ Physiol
261:
H1464-H1470,
1991
16.
Kalsner, S.
Non-neurogenic contraction in isolated coronary arteries by brief electrical pulse.
Cardiovasc Res
28:
1835-1842,
1994
17.
Kalsner, S.
Vasodilator action of calcium antagonists in coronary arteries in vitro.
J Pharmacol Exp Ther
281:
634-642,
1997
18.
Kamishima, T,
and
McCarron JG.
Regulation of the cytosolic Ca2+ concentration by Ca2+ stores in single smooth muscle cells from rat cerebral arteries.
J Physiol (Lond)
501:
497-508,
1997[ISI][Medline].
19.
Kannan, MS,
Fenton AM,
Prakash YS,
and
Sieck GC.
Cyclic ADP-ribose stimulates sarcoplasmic reticulum calcium release in porcine coronary artery smooth muscle.
Am J Physiol Heart Circ Physiol
270:
H801-H805,
1996
20.
Knot, HJ,
Standen NB,
and
Nelson MT.
Ryanodine receptors regulate arterial diameter, and wall [Ca2+] in cerebral arteries of rat via Ca2+-dependent K+ channels.
J Physiol (Lond)
508:
211-221,
1998
21.
Lahouratate, P,
Guibert J,
and
Faivre JF.
cADP-ribose release Ca2+ from cardiac sarcoplasmic reticulum independently of ryanodine receptor.
Am J Physiol Heart Circ Physiol
273:
H1082-H1089,
1997
22.
Lee, HC.
Potentiation of calcium- and caffeine-induced calcium release by cyclic ADP- ribose.
J Biol Chem
268:
293-299,
1993
23.
Lee, HC.
A signaling pathway involving cyclic ADP-ribose, cGMP, and nitric oxide.
News Physiol Sci
9:
134-137,
1994
24.
Lee, HC,
and
Aarhus R.
Wide distribution of an enzyme that catalyzes the hydrolysis of cyclic ADP-ribose.
Biochim Biophys Acta
1164:
68-74,
1993[Medline].
25.
Lee, HC,
Aarhus R,
Graeff R,
Gurnack ME,
and
Walseth TF.
Cyclic ADP-ribose activation of the ryanodine receptor is mediated by calmodulin.
Nature
370:
307-309,
1994[Medline].
26.
Lee, HC,
Aarhus R,
and
Gruff RM.
Sensitization of calcium-induced calcium release by cyclic ADP-ribose and calmodulin.
J Biol Chem
270:
9060-9066,
1995
27.
Lesh, RE,
Nixon GF,
Fleischer S,
Airey JA,
Somlyo AP,
and
Somlyo AV.
Localization of ryanodine receptors in smooth muscle.
Circ Res
82:
175-185,
1998
28.
Li, N,
Teggatz EG,
Li P-L,
Campbell WB,
and
Zou A-P.
Cyclic ADP-ribose-mediated Ca2+ signaling and Ca2+-induced Ca2+ release in preglomerular arterial smooth muscle cells (Abstract).
FASEB J
14:
A130,
2000.
29.
Li, P-L,
Zou A-P,
Al-kayed NJ,
Rusch NJ,
and
Harder DR.
Guanine nucleotide-binding protein in aortic smooth muscle from hypertensive rats.
Hypertension
23:
914-918,
1994
30.
Li, P-L,
Zou A-P,
and
Campbell WB.
Metabolism and actions of ADP-riboses in coronary arterial smooth muscle.
Adv Exp Med Biol
419:
437-441,
1997[ISI][Medline].
31.
Li, P-L,
Zou A-P,
and
Campbell WB.
Regulation of the KCa channel activity by cADP-riboses and ADP-ribose in bovine coronary arterial smooth muscle.
Am J Physiol Heart Circ Physiol
275:
H1002-H1010,
1998
32.
Lokuta, AJ,
Meyers MB,
Sander PR,
Fishman GI,
and
Valdivia HH.
Modulation of cardiac ryanodine receptor by sorcin.
J Biol Chem
272:
25333-25338,
1997
33.
Lokuta, AJ,
Rogers TB,
Lederer WJ,
and
Valdivia HH.
Modulation of cardiac ryanodine receptors of swine and rabbit by a phophorylation-dephosphorylation mechanism.
J Physiol (Lond)
487:
609-622,
1995[ISI][Medline].
34.
Lynn, S,
and
Gillespie JI.
Basic properties of a novel ryanodine-sensitive, caffeine-insensitive calcium-induced calcium release mechanism in permeabilised human vascular smooth muscle cells.
FEBS Lett
367:
23-27,
1995[ISI][Medline].
35.
Meszaros, LG,
Bak J,
and
Chiu A.
Cyclic ADP-ribose as an endogenous regulator of the non-skeletal type ryanodine receptor Ca2+ channel.
Nature
364:
76-79,
1993[Medline].
36.
Morita, K,
Kitayama S,
and
Dohi T.
Stimulation of cyclic ADP-ribose synthesis by acetylcholine and its role in catecholamine release in bovine adrenal chromaffin cells.
J Biol Chem
272:
21002-21009,
1997
37.
Noguchi, N,
Takasawa S,
Nata K,
Tohgo A,
Kato I,
Ikehata F,
Yonekura H,
and
Okamoto H.
Cyclic ADP-ribose binds to FK506-binding protein 12.6 to release Ca2+ from islet microsome.
J Biol Chem
272:
3133-3136,
1997
38.
Sitsapesan, R,
McGarry SJ,
and
Williams AJ.
Cyclic ADP-ribose competes with ATP for the adenine nucleotide binding site on the cardiac ryanodine receptor Ca2+-release channel.
Circ Res
75:
596-600,
1994
39.
Sitsapesan, R,
McGarry SJ,
and
Williams AJ.
Cyclic ADP-ribose, the ryanodine receptor and Ca2+ release.
Trends Pharmacol Sci
16:
386-391,
1995[Medline].
40.
Takesawa, S,
Nata K,
Yonekura H,
and
Okamoto H.
Cyclic ADP-ribose in insulin secretion from pancreatic cells.
Science
259:
370-373,
1993
41.
Tanaka, Y,
and
Tashjian AH, Jr.
Calmodulin is a selective mediator of Ca2+-induced Ca2+ release via the ryanodine receptor-like Ca2+ channel triggered by cyclic ADP-ribose.
Proc Natl Acad Sci USA
92:
3244-3248,
1995
42.
Tripathy, A,
Resch W,
Xu L,
Valdivia HH,
and
Meissner G.
Imperatoxin A induced subconductance states in Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle.
J Gen Physiol
111:
679-690,
1998
43.
Ullmer, C,
Boddeke HG,
Schmuck K,
and
Lubbert H.
5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular store in human pulmonary artery endothelial cells.
Br J Pharmacol
117:
1081-1088,
1996[ISI][Medline].
44.
Valdivia, HH.
Modulation of intracellular Ca2+ level in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors.
Trends Pharmacol Sci
19:
479-482,
1998[Medline].
45.
Wahner-Mann, C,
Hu Q,
and
Sturek M.
Multiple effect of ryanodine on intracellular free Ca2+ in smooth muscle cells from bovine and porcine coronary artery: modulation of sarcoplasmic reticulum function.
Br J Pharmcol
105:
903-911,
1992[ISI][Medline].
46.
White, AM,
Watson SP,
and
Galione A.
Cyclic ADP-ribose-induced Ca2+ release from rat brain microsomes.
FEBS Lett
318:
259-263,
1993[ISI][Medline].
47.
Yu, J-Z,
Li P-L,
and
Campbell WB.
Nitric oxide inhibits intracellular calcium mobilization through cADP-ribose signaling pathway in coronary arterial smooth muscle cells (Abstract).
Hypertension
32:
599,
1998.
48.
Zamudio, FZ,
Conde R,
Arevalo C,
Becerril B,
Martin BM,
Valdivia HH,
and
Possani LD.
The mechanism of inhibition of ryanodine channels by imperatoxin I, a heterodimeric protein from scorpion Pandinus imperator.
J Biol Chem
272:
11886-11894,
1997
This article has been cited by other articles:
![]() |
J. A. Jude, M. E. Wylam, T. F. Walseth, and M. S. Kannan Calcium Signaling in Airway Smooth Muscle Proceedings of the ATS, January 1, 2008; 5(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang and P.-L. Li Reconstitution and Characterization of a Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-sensitive Ca2+ Release Channel from Liver Lysosomes of Rats J. Biol. Chem., August 31, 2007; 282(35): 25259 - 25269. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, G. Zhang, A. Y. Zhang, M. J. Koeberl, E. Wallander, and P.-L. Li Production of NAADP and its role in Ca2+ mobilization associated with lysosomes in coronary arterial myocytes Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H274 - H282. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Yi, V. X. Li, F. Zhang, F. Yi, D. R. Matson, M. T. Jiang, and P.-L. Li Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1136 - H1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, E. G. Teggatz, A. Y. Zhang, M. J. Koeberl, F. Yi, L. Chen, and P.-L. Li Cyclic ADP ribose-mediated Ca2+ signaling in mediating endothelial nitric oxide production in bovine coronary arteries Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1172 - H1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Deshpande, T. A. White, S. Dogan, T. F. Walseth, R. A. Panettieri, and M. S. Kannan CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L773 - L788. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Fellner and W. J. Arendshorst Angiotensin II Ca2+ signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways Am J Physiol Renal Physiol, April 1, 2005; 288(4): F785 - F791. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Fellner and L. Parker Endothelin-1, superoxide and adeninediphosphate ribose cyclase in shark vascular smooth muscle J. Exp. Biol., March 15, 2005; 208(6): 1045 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Lee, D. Poburko, K.-H. Kuo, C. Y. Seow, and C. van Breemen Ca2+ oscillations, gradients, and homeostasis in vascular smooth muscle Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1571 - H1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-X. Tang, Y.-F. Chen, A.-P. Zou, W. B. Campbell, and P.-L. Li Role of FKBP12.6 in cADPR-induced activation of reconstituted ryanodine receptors from arterial smooth muscle Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1304 - H1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Li, D. X. Zhang, Z.-D. Ge, and W. B. Campbell Role of ADP-ribose in 11,12-EET-induced activation of KCa channels in coronary arterial smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1229 - H1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lukyanenko, I. Gyorke, T. F. Wiesner, and S. Gyorke Potentiation of Ca2+ Release by cADP-Ribose in the Heart Is Mediated by Enhanced SR Ca2+ Uptake Into the Sarcoplasmic Reticulum Circ. Res., September 28, 2001; 89(7): 614 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Zhang, Y.-F. Chen, W. B. Campbell, A.-P. Zou, G. J. Gross, and P.-L. Li Characteristics and Superoxide-Induced Activation of Reconstituted Myocardial Mitochondrial ATP-Sensitive Potassium Channels Circ. Res., December 7, 2001; 89(12): 1177 - 1183. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||